Effect of Combined Folic Acid, Vitamin B6, and Vitamin B12 on Colorectal Adenoma
Open accessThe DOI matches its Crossref record; 27 of the 29 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Folic acid, vitamin B(6), and vitamin B(12) act in concert in the one-carbon metabolism and may protect against colorectal neoplasia. We examined the effect of combined B-vitamin treatment on the occurrence of colorectal adenoma. METHODS: The Women's Antioxidant and Folic Acid Cardiovascular Study was a randomized, double-blind, placebo-controlled trial of 5442 female health professionals at high risk for cardiovascular disease from April 1998 through July 2005. Participants were randomly assigned to receive a combination pill of folic acid (2.5mg), vitamin B(6) (50mg), and vitamin B(12) (1mg) or placebo. This study included 1470 participants who were followed up for as long as 9.2 years and underwent an endoscopy at any point during follow-up. We estimated relative risks using a generalized linear model with a natural logarithm link function and Poisson distributed errors. All statistical tests were two-sided. RESULTS: The risk of colorectal adenoma was similar among participants receiving treatment (24.3%, 180 of 741 participants) vs placebo (24.0%, 175 of 729 participants) (multivariable adjusted relative risk = 1.00, 95% confidence interval = 0.83 to 1.20). Treatment was not associated with the risk of adenoma when data were analyzed by subsite, size, stage, and the number of adenomas. There was no statistically significant effect modification by alcohol intake, history of cancer or adenoma, or baseline plasma levels or intakes of folate, vitamin B(6), or vitamin B(12). CONCLUSION: Our results indicate no statistically significant effect of combined folic acid, vitamin B(6), and vitamin B(12) treatment on colorectal adenoma among women at high risk for cardiovascular disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Disappointingly, however, intervention trials have failed to demonstrate a reduction of cancer risk in individuals randomized to receive folic acid supplements compared to controls (Andreeva et al., 2012; Cole et al., 2007; Song et al., 2012; Zhang et al., 2008).”
From Influence of Metabolism on Epigenetics and Disease (2013) · cites this paper as Song et al., 2012
Citations
Cites
Surveillance for dracunculiasis, 1981-1991.
Hopkins, D. R., & Ruiz‐Tiben, E. (1992) · PubMed · Cited by 1,110
Araki, A., & Sako, Y. (1987) · Journal of Chromatography B: Biomedical Sciences and Applications · doi:10.1016/0378-4347(87)80438-3 · Cited by 1,041 · cited 1×
“Plasma homocysteine, cysteine, and cysteinylglycine were measured using high-performance liquid chromatography, with fluorescence detection (17).”
MethodFolic Acid for the Prevention of Colorectal Adenomas: A Randomized Clinical Trial
Cole, B. F., Baron, J. A., Sandler, R. S., Haile, R. W., Ahnen, D. J., Bresalier, R. S., McKeown-Eyssen, G., Summers, R. W., Rothstein, R. I., Burke, C. A., et al. (2007) · JAMA · doi:10.1001/jama.297.21.2351 · Cited by 929 · cited 1×
“multiple adenomas after an additional 3–5 years of intervention (20).”
Background(1992) · PsycEXTRA Dataset · doi:10.1037/e546602006-001 · Cited by 923
Dietary Supplement Use in the United States, 2003–2006
Bailey, R. L., Gahche, J. J., Lentino, C. V., Dwyer, J. T., Engel, J. S., Thomas, P. R., Betz, J. M., Sempos, C. T., & Picciano, M. F. (2011) · The Journal of Nutrition · doi:10.3945/jn.110.133025 · Cited by 812 · cited 1×
“Because 28%–35% of the US population report the use of dietary supplements that contain folic acid and vitamins B6 and B12 (9,10), definitive data from large randomized trials with long treatment duration are warranted to evaluate the potential yet unproven benefits or risks of combined folic acid, vitamin B6, and vit…”
BackgroundIs folic acid good for everyone?
Smith, A. D., Kim, Y.-I., & Refsum, H. (2008) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/87.3.517 · Cited by 612
Albert, C. M., Cook, N. R., Gaziano, J. M., Zaharris, E., MacFadyen, J., Danielson, E., Buring, J. E., & Manson, J. E. (2008) · JAMA · doi:10.1001/jama.299.17.2027 · Cited by 511 · cited 4×
“0% of person-years of follow-up, respectively (11,13,14).”
BackgroundMethodSelf-citationCook, N. R. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.15.1610 · Cited by 479 · cited 1×
“0% of person-years of follow-up, respectively (11,13,14).”
Self-citationEpidemiologic Studies of Folate and Colorectal Neoplasia: a Review
Giovannucci, E. (2002) · The Journal of Nutrition · doi:10.1093/jn/132.8.2350s · Cited by 448 · cited 6×
“5–5 mg/d for as long as 3 years) on recurrence of colorectal adenomas (1,2,5,6).”
BackgroundSelf-citationFolate and colorectal cancer: An evidence‐based critical review
Kim, Y. (2007) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200600191 · Cited by 419 · cited 6×
“5–5 mg/d for as long as 3 years) on recurrence of colorectal adenomas (1,2,5,6).”
BackgroundInfluential
Research works printed but not linked: 1
- Food and Drug Administration, Dept of Health and Human Services., 1996, Food standards, Fedral Register, 61, 8781
Cited by
Influence of Metabolism on Epigenetics and Disease
Kaelin, W. G., & McKnight, S. L. (2013) · Cell · doi:10.1016/j.cell.2013.03.004 · Cited by 920
“Disappointingly, however, intervention trials have failed to demonstrate a reduction of cancer risk in individuals randomized to receive folic acid supplements compared to controls (Andreeva et al., 2012; Cole et al., 2007; Song et al., 2012; Zhang et al., 2008).”
Wilson, R. D., Wilson, R. D., Audibert, F., Brock, J.-A., Carroll, J., Cartier, L., Gagnon, A., Johnson, J.-A., Langlois, S., Murphy-Kaulbeck, L., et al. (2015) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/s1701-2163(15)30230-9 · Cited by 259
Dietary supplements and disease prevention — a global overview
Rautiainen, S., Manson, J. E., Lichtenstein, A. H., & Sesso, H. D. (2016) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.54 · Cited by 250
Self-citationMoazzen, S., Dolatkhah, R., Tabrizi, J. S., Shaarbafi, J., Alizadeh, B. Z., de Bock, G. H., & Dastgiri, S. (2017) · Clinical Nutrition · doi:10.1016/j.clnu.2017.10.010 · Cited by 121
Role of vitamins in gastrointestinal diseases
Masri, O., Chalhoub, J. M., & Sharara, A. I. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i17.5191 · Cited by 85
Liu, Y., Yu, Q., Zhu, Z., Zhang, J., Chen, M., Tang, P.-Y., & Li, K. (2014) · Medical Oncology · doi:10.1007/s12032-014-0434-5 · Cited by 63
“rectal adenoma risk among women at high risk of cardiovascular disease [60].”
Wilson, R. D., & O’Connor, D. L. (2021) · Preventive Medicine Reports · doi:10.1016/j.pmedr.2021.101617 · Cited by 71
Bonovas, S., Fiorino, G., Lytras, T., Malesci, A., & Danese, S. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i18.4594 · Cited by 57
Obeid, R. (2022) · Nutrients · doi:10.3390/nu14214476 · Cited by 52
“Two publications found no increase in the risk of cancer [26,28]; two publications reported an increased risk of cancer or cancer mortality [25,29]; and one study found a higher risk of cancer in a subgroup of patients with diabetes [27].”
BackgroundMultivitamin, calcium and folic acid supplements and the risk of colorectal cancer in Lynch syndrome
Chau, R., Dashti, S. G., Ouakrim, D. A., Buchanan, D. D., Clendenning, M., Rosty, C., Winship, I., Young, J. P., Giles, G. G., Macrae, F., et al. (2016) · International Journal of Epidemiology · doi:10.1093/ije/dyw036 · Cited by 36
Chuang, S., Rota, M., Gunter, M. J., Zeleniuch‐Jacquotte, A., Eussen, S. J. P. M., Vollset, S. E., Ueland, P. M., Norat, T., Ziegler, R. G., & Vineis, P. (2013) · American Journal of Epidemiology · doi:10.1093/aje/kwt083 · Cited by 27
Emami, M. H., Salehi, M., Keshteli, A. H., Mansourian, M., Mohammadzadeh, S., & Maghool, F. (2021) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2021.1911927 · Cited by 21
“Potential compounds have been introduced as chemo-preventive agents for CAs such as vitamins A, B, C, E, fibers, some drugs, and calcium (Newmark, Wargovich, and Bruce 1984; Greenberg et al. 1994; Baron et al. 2003; Song et al. 2012; Thompson et al. 2012).”
BackgroundHeer, E. V., Ruan, Y., Mah, B., Nguyen, T. T., Lyons, H., Poirier, A. E., Boyne, D. J., O'Sullivan, D. E., Heitman, S. J., Hilsden, R. J., et al. (2022) · Preventive Medicine · doi:10.1016/j.ypmed.2022.107169 · Cited by 24
Jung, A. Y., van Duijnhoven, F. J. B., Nagengast, F. M., Botma, A., Heine-Bröring, R. C., Kleibeuker, J. H., Vasen, H. F. A., Harryvan, J. L., Winkels, R. M., & Kampman, E. (2014) · Cancer Causes & Control · doi:10.1007/s10552-014-0412-4 · Cited by 16
“and combined folic acid, vitamin B6, and vitamin B12 supplementation and sporadic CRA development [59].”
BackgroundGenetically predicted circulating B vitamins in relation to digestive system cancers
Yuan, S., Carter, P., Vithayathil, M. K., Kar, S., Mason, A. M., Burgess, S., & Larsson, S. C. (2021) · British Journal of Cancer · doi:10.1038/s41416-021-01383-0 · Cited by 20
Unge på Kanten - Om inkludering av utsatte ungdommer
Publikation, N. (2012) · doi:10.6027/nord2012-005 · Cited by 45
Vitamin B12: Could It Be a Promising Immunotherapy?
Todorova, T., Ermenlieva, N., & Tsankova, G. S. (2017) · InTech eBooks · doi:10.5772/65729 · Cited by 21
“Similarly, increased intake of it does not correlate with decreased risk of colorectal cancer [57], and also there is no significant effect when combine with folic acid and vitamin B6 on colorectal adenoma [58] and on total invasive cancer or breast cancer risk [59] among women at high risk for cardiovascular disease.”
BackgroundZhao, L., Cheng, Z., Lu, Z.-Y., & Jin, J.-Q. (2021) · Translational Cancer Research · doi:10.21037/tcr-20-2798 · Cited by 10
“Transl Cancer Res 2021;10(3):1457-1469 | http://dx.”
BackgroundMa, Y., You, W., Cao, Y., He, X., Wang, J., Zhang, Y., Li, J., & Li, J. (2023) · Chinese Medical Journal · doi:10.1097/cm9.0000000000002514 · Cited by 11
“Recent randomized controlled trials (RCTs) have reported favorable preventive effects of many nutritional supplements and pharmacological agents on colorectal adenoma and CRC.[4-15] Current pairwise systematic reviews and meta-analyses have suggested that nonsteroidal anti-inflammatory drugs, including aspirin and cyc…”
BackgroundResultInfluentialDing, H., Gao, Q., Chen, H., & Fang, J. (2016) · Journal of International Medical Research · doi:10.1177/0300060516650075 · Cited by 8
“Conflicting results regarding the efficacy of folate have mainly come from clinical trials that measured the effect of folate supplements rather than analysing serum levels of folate.(10) Meanwhile, few of the studies considered advanced colorectal adenoma (ACRA),(13,14) which ismost likely to progress to CRC.”
BackgroundFolic Acid, Selected Cancers and All-cause Mortality: A Meta-analysis
Mackerras, D., Tan, J., & Larter, C. Z. (2014) · International Food Risk Analysis Journal · doi:10.5772/58396 · Cited by 9
“Song [80] (2.”
InfluentialMishra, P., Beura, S., Ghosh, R., & Modak, R. (2022) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-3-031-07634-3_8 · Cited by 8
Circulating folate levels and colorectal adenoma: a case-control study and a meta-analysis
Park, Y. M., Youn, J., Cho, C. H., Kim, S. H., & Lee, J. E. (2017) · Nutrition Research and Practice · doi:10.4162/nrp.2017.11.5.419 · Cited by 7
“Regarding the randomized doublebind clinical trial studies of supplements [12,18-20], if the supplement in the intervention group contained folic acid, we used the RRs and 95% CIs for colorectal adenoma recurrence only in the placebo group [18] or calculated the crude RRs and 95% CIs using the number of cases and non-…”
BackgroundMethodResultInfluentialFollowing Up Folate and Its Function in Colorectal Carcinogenesis
Ziegler, R. G. (2012) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djs412 · Cited by 4
Wilson, R. D. (2016) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/j.jogc.2016.09.069 · Cited by 3
Genome‐wide association study of circulating folate one‐carbon metabolites
Wang, J., Asante, I., Baron, J. A., Figueiredo, J. C., Haile, R. W., Levine, A. J., Newcomb, P. A., Templeton, A. S., Schumacher, F. R., Louie, S. G., et al. (2019) · Genetic Epidemiology · doi:10.1002/gepi.22249 · Cited by 3
“Several other trials reported no such effect (Logan, Grainge, Shepherd, Armitage, & Muir, 2008; Song et al., 2012; Wu et al., 2009), although they had shorter follow‐up periods.”
BackgroundAssociation between Vitamin B12 Levels and Colon Cancer Survival: A Global Network Study
Chang-Gu, B., Golovko, G., D’Andrea, A. P., & Khanipov, K. (2026) · Cancer Research Communications · doi:10.1158/2767-9764.crc-25-0557 · Cited by 2
“Although the association between B 12 intake and cancer incidence/survival remains controversial (6, 19–23), epidemiologic studies have reported chronic elevated B 12 to be linked to an increased incidence of lung (24, 25) and colorectal (26) cancer.”
A Chemopreventive Cocktail on the Rocks
Crockett, S. D., & Baron, J. A. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.11.031 · Cited by 2
Masih, S. P., Plumptre, L., & Kim, Y. (2014) · Springer eBooks · doi:10.1007/978-1-4939-0706-9_11 · Cited by 3
Update 2013 Komplementäre Onkologie
Hübner, J. (2013) · Der Onkologe · doi:10.1007/s00761-013-2541-x · Cited by 2
Twum, F., Cowan, L., Yu, L., Afriyie-Gyawu, E., & Zhang, J. (2024) · Nutrition Research · doi:10.1016/j.nutres.2024.04.005 · Cited by 1
Chemoprevention of Colorectal Cancer in Inflammatory Bowel Disease
Han, S., & Lee, J. H. (2014) · Korean Journal of Gastroenterology · doi:10.4166/kjg.2014.63.1.3 · Cited by 1
“Folic acid Folic acid의 부족은 산발성 대장암의 원인 중 하나다.(51) Folic acid는 유전자의 합성 및 보수와 세포사멸의 조절에 있 어 중요역할을 하며, folic acid의 부족은 nuclear factor-kppa B (NF-κB) 기전에 교차반응을 일으켜 sonic hedgehog (Shh) 신호를 활성화시켜 대장암의 침습성을 높인다.”
Dietary Supplements in Older Adults
Dwyer, J. T., Costello, R. B., Merkel, J. M., & Coates, P. M. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1929-1_23 · Cited by 1
Chromatin, histones, and histone modifications in health and disease
Shah, S. G., Rashid, M., Verma, T., & Gupta, S. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-817819-5.00008-5 · Cited by 3
The micronutrient profile of the typical American diet enhances colorectal carcinogenesis
Monsanto, S. P. (2013) · Digital Commons - USU (Utah State University) · doi:10.26076/9bff-173a
Considerations for Care: Management of Asthma in the Child with Sickle Cell Disease
Blake, K., & Raissy, H. (2013) · Pediatric Allergy Immunology and Pulmonology · doi:10.1089/ped.2013.0124
“35,36 40 Montelukast is the preferred leukotriene modifier in patients with asthma and sickle cell disease because of its well-established effects on the improvements of asthma symptoms, once daily dosing, and its safety record (similar to placebo) that extends over 10 years of use in millions of…”
Odion, B. E., Cowan, L., Yu, L., & Zhang, J. (2024) · European Journal of Cancer Prevention · doi:10.1097/cej.0000000000000927
Su, L. J., O’Connor, S., Aguilar, D. R., Lee, M., Wong, H., Lin, H.-Y., Bensen, J. T., Mohler, J. L., Arab, L., Zhao, L., et al. (2026) · Nutrients · doi:10.3390/nu18050748
Metadata
- Authors
- Song, Y., Manson, J. E., Lee, I.-M., Cook, N. R., Paul, L., Selhub, J., Giovannucci, E., & Zhang, S. M.
- Affiliations
- Tufts University (US)
- Venue
- JNCI: Journal of the National Cancer Institute
- Publisher
- Oxford University Press (OUP)
- Published
- 2012-10-12
- Volume
- 104
- Issue
- 20
- Pages
- 1562-1575
- ISSN
- 0027-8874 (ISSN-L)
- 1460-2105
- PMC
- PMC3611818
- OpenAlex
- W2165640959
- Cited by
- 38
- References
- 29
- Citations by year
- 2026: 2 · 2024: 2 · 2023: 1 · 2022: 3 · 2021: 5 · 2020: 1 · 2019: 1 · 2017: 3 · 2016: 5 · 2015: 3 · 2014: 6 · 2013: 4 · 2012: 2
- FWCI
- 3.67
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- JNCI Journal of the National Cancer Institute (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- HighWire Press Open Archive (submittedVersion)
- Funders
- National Heart, Lung, and Blood Institute (HL046959, R01HL046959)
- National Cancer Institute (R01CA104871, R01CA123089, CA124857, R01CA124857, CA104871, CA123089)
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Folate and B Vitamins Research
- Health Sciences › Medicine › Oncology › Colorectal Cancer Screening and Detection
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Nutritional Studies and Diet
- Keywords
- folic acid, vitamin B6, vitamin B12, colorectal adenoma, one-carbon metabolism, vitamin B supplementation
- MeSH terms
- Adenoma, Adult, Aged, Cardiovascular Diseases, Double-Blind Method, Drug Therapy, Combination, Female, Folic Acid, Follow-Up Studies, Humans, Male, Middle Aged, Risk Factors, Vitamin B 12, Colorectal Neoplasms, Incidence, Poisson Distribution, Linear Models, Anticarcinogenic Agents, Risk Assessment, Vitamin B 6
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.